Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

about

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

Item

http://www.wikidata.org/entity/Q40242986

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

@en

type

Item

label

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

@en

prefLabel

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

@en

P1476

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

@en

P2093

Hester E de Melker

http://www.w3.org/2001/XMLSchema#string

Jeanet M Kemmeren

http://www.w3.org/2001/XMLSchema#string

Nicoline At van der Maas

http://www.w3.org/2001/XMLSchema#string

P2860

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)

No adjustments are needed for multiple comparisons

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team.

Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases.

Mechanisms underlying adverse reactions to vaccines.

Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.

10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

P2888

s00431-017-2901-4

P304

757-768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00431-017-2901-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28429115

http://www.w3.org/2001/XMLSchema#string

P921

Alamad